A strategic partnership focused on developing advanced medical technologies, imaging and in vitro diagnostics.
The alliance builds on a ten-year collaboration between the global healthcare solutions company and the University, supporting innovation in world-class imaging research and precision diagnostics.
Cardiff University Brain Research Imaging Centre (CUBRIC), led by Professor Derek Jones, is at the heart of the partnership, bringing together magnetic resonance (MR) technology from Siemens Healthineers with Cardiff’s world-leading expertise in brain mapping and clinical innovation.
This unique strategic collaboration will significantly accelerate innovative advancements that will transform how we understand and treat neurological diseases, making CUBRIC an epicentre for European Neuroimaging. Playing a pivotal role in the global effort to better understand the causes of neurological conditions such as dementia, schizophrenia, and multiple sclerosis, the partnership is committed to delivering real world impact that will positively change the lives and experience of those in the healthcare system.
Key themes for the Strategic Partnership include:
- Medical Imaging
- Precision Diagnostics
- Advanced Therapies (emerging)
- Digital Health
Aims and objectives
The partnership will support the aims of Siemens Healthineers across research and development, talent, skills, diversity and civic and social responsibility. Convening other Cardiff partners, including the NHS, it aims to empower healthcare providers to achieve better patient outcomes at lower cost, by expanding precision medicine, improving patient experience, and digitising healthcare.
The partners will work together to harness innovations in MR hardware, biophysical modelling and MR acquisition strategies using Artificial Intelligence to develop highly efficient acquisition protocols to capture intricate 'fingerprints' of tissue microstructure in health, developmental processes, aging, and various disease states. This will transform the understanding of complex biological systems and enable earlier diagnosis and treatment of neurological and psychiatric conditions such as dementia, epilepsy, multiple sclerosis and schizophrenia.
Moreover, integration of imaging and biochemical analysis modalities will provide innovative approaches to the diagnosis and treatment of other conditions including cancer and diseases associated with infection and immunity.
CUBRIC's research facilities include the 3 Tesla MAGNETOM Skyra Connectom MRI system from Siemens Healthineers, a specially adapted MRI scanner with unparalleled gradient strength, of which there are only four in the world.
The partnership builds on existing collaborations in the field of clinical laboratory diagnostics including:
- CUBRIC hosts one onsite scientist from Siemens Healthineers, developing collaborative projects with CUBRIC researchers to create a step-change in imaging technology.
- CUBRIC has already leveraged the power of Siemens Healthineers imaging technology to secure grant income of over £54.5 million.
If you have queries or questions about the partnership, please contact the university's Partnership Manager:
Strategic partnerships manager
Learn how our cutting-edge research, technology transfer, business development and student enterprise drive our vision.